New York State Teachers Retirement System cut its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 1.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 69,402 shares of the company’s stock after selling 1,100 shares during the quarter. New York State Teachers Retirement System owned 0.14% of Prestige Consumer Healthcare worth $4,347,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in PBH. BlackRock Inc. lifted its stake in Prestige Consumer Healthcare by 12.4% during the first quarter. BlackRock Inc. now owns 9,115,718 shares of the company’s stock worth $482,584,000 after purchasing an additional 1,004,337 shares during the last quarter. Norges Bank bought a new position in Prestige Consumer Healthcare during the fourth quarter worth $35,336,000. Nordea Investment Management AB lifted its stake in Prestige Consumer Healthcare by 72.1% in the fourth quarter. Nordea Investment Management AB now owns 1,030,901 shares of the company’s stock valued at $65,277,000 after buying an additional 431,813 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Prestige Consumer Healthcare by 3.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,674,930 shares of the company’s stock valued at $230,053,000 after buying an additional 116,613 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its stake in Prestige Consumer Healthcare by 212.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 163,218 shares of the company’s stock valued at $10,217,000 after buying an additional 111,046 shares during the last quarter. 99.96% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
PBH has been the topic of a number of recent research reports. 3M reiterated a “reiterates” rating on shares of Prestige Consumer Healthcare in a research note on Monday, June 26th. TheStreet cut Prestige Consumer Healthcare from a “b+” rating to a “c+” rating in a research note on Thursday, May 4th. Finally, StockNews.com cut Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 24th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $82.00.
Prestige Consumer Healthcare Price Performance
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) last issued its quarterly earnings results on Thursday, May 4th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.03. The company had revenue of $285.90 million for the quarter, compared to analyst estimates of $280.58 million. Prestige Consumer Healthcare had a positive return on equity of 13.38% and a negative net margin of 7.30%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company earned $0.91 earnings per share. Equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.3 EPS for the current year.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Read More
- Five stocks we like better than Prestige Consumer Healthcare
- MarketBeat Week in Review – 7/17 – 7/21
- U.S. Bancorp Shares Rally As Analysts Get Bullish After Q2 Report
- AutoNation Beats Earnings Expectations, Stock Down?
- American Express Hiccups After Earnings, Time To Buy?
- ISRG Stock Sinks After Strong Earnings: Is the Growth Priced In?
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
